Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Total Debt (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Total Debt data on record, last reported at $150000.0 in Q3 2025.

  • For Q3 2025, Total Debt changed 0.0% year-over-year to $150000.0; the TTM value through Sep 2025 reached $150000.0, changed 0.0%, while the annual FY2024 figure was $1.2 million, 694.32% up from the prior year.
  • Total Debt reached $150000.0 in Q3 2025 per COEP's latest filing, roughly flat from $150000.0 in the prior quarter.
  • Across five years, Total Debt topped out at $1.6 million in Q4 2021 and bottomed at $150000.0 in Q4 2022.
  • Average Total Debt over 5 years is $377353.9, with a median of $150000.0 recorded in 2022.
  • Peak YoY movement for Total Debt: crashed 90.91% in 2022, then surged 694.32% in 2024.
  • A 5-year view of Total Debt shows it stood at $1.6 million in 2021, then plummeted by 90.91% to $150000.0 in 2022, then changed by 0.0% to $150000.0 in 2023, then soared by 694.32% to $1.2 million in 2024, then plummeted by 87.41% to $150000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Total Debt were $150000.0 in Q3 2025, $150000.0 in Q2 2025, and $785489.0 in Q1 2025.